SERA Return on Tangible Equity | SERA PROGNOSTICS, INC.

SERA PROGNOSTICS, INC. (SERA) Return on Tangible Equity

2026-06-30: Return Tang Equity -56.63%.
2026-03-31: Return Tang Equity -48.03%.
2025-12-31: Return Tang Equity -42.74%.
2025-09-30: Return Tang Equity -40.04%.

Complete source-backed return tang equity history.

Available history: 2020-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-56.63%
2026-03-31	-48.03%
2025-12-31	-42.74%
2025-09-30	-40.04%
2025-06-30	-37.40%
2025-03-31	-35.06%
2024-12-31	-69.84%
2024-09-30	-59.77%
2024-06-30	-53.40%
2024-03-31	-52.73%
2023-12-31	-51.66%
2023-09-30	-50.47%
2023-06-30	-51.23%
2023-03-31	-47.16%
2022-12-31	-44.66%
2022-09-30	-43.79%
2022-06-30	-39.41%
2022-03-31	-32.12%
2021-12-31	-25.27%
2021-09-30	-18.60%
2021-06-30	17.02%
2021-03-31	16.50%
2020-12-31	15.81%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-42.34%
2024-12-31	-68.82%
2023-12-31	-51.66%
2022-12-31	-44.66%
2021-12-31	-25.27%
2020-12-31	15.81%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
AMERICAN SHARED HOSPITAL SERVICES (AMS)	United States	$0.010B	-5.64
Advanced Biomed Inc. (ADVB)		$0.009B
Aclarion, Inc. (ACON)	United States	$0.008B
BioNexus Gene Lab Corp (BGLC)		$0.004B
Freenome, Inc. (FRNM)	United States	$0.143B
EXAGEN INC. (XGN)	United States	$0.212B	-5.95
BIODESIX INC (BDSX)	United States	$0.312B
Fulgent Genetics, Inc. (FLGT)	United States	$0.593B	-6.70
Lumexa Imaging Holdings, Inc. (LMRI)	United States	$0.951B
CASTLE BIOSCIENCES INC (CSTL)	United States	$1.074B	-37.45